Related Experiment Video

Updated: Jun 26, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Diagnosis of chronic hepatitis B and the implications of viral variants and mutations

Robert G Gish1

  • 1Liver Transplant Program, California Pacific Medical Center, San Francisco, California 94115, USA. gishr@sutterhealth.org

The American Journal of Medicine
|February 3, 2009
PubMed

Insights

Accurate diagnosis and treatment of chronic hepatitis B virus (HBV) infection are crucial globally. Increased screening and vaccination in high-risk communities are recommended to manage rising HBV prevalence.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Chronic hepatitis B virus (HBV) infection is a significant global health concern causing substantial morbidity and mortality.
  • While US HBV prevalence is low due to vaccination, immigration trends predict an increase, necessitating proactive public health measures.
  • High-risk populations, including Asian Americans, require targeted screening (hepatitis B surface antigen) and vaccination programs.

Purpose of the Study:

  • To emphasize the need for accurate diagnosis and optimal treatment strategies for chronic HBV infection.
  • To highlight the importance of screening and vaccination programs for at-risk communities.
  • To discuss the role of advanced diagnostic techniques and viral markers in managing HBV.

Main Methods:

  • Utilizing serologic technologies for disease staging and subtype identification.
  • Employing nucleic acid testing for viral load quantification and variant analysis.
  • Monitoring serial HBV DNA levels to assess therapeutic response.

Main Results:

  • Serologic and nucleic acid tests provide critical data on disease stage, viral load, and HBV subtypes.
  • Precore and core promoter variants serve as prognostic indicators, guiding patient management.
  • Serial DNA monitoring is essential for evaluating treatment effectiveness and directing therapy.

Conclusions:

  • Active screening and vaccination programs are vital for controlling HBV, especially in immigrant populations.
  • Advanced diagnostic tools and monitoring of viral markers are key to effective HBV management.
  • Further research is needed to understand HBV variants' impact on treatment efficacy.

More Related Videos

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...